Appearing before a Senate committee Thursday, the CEOs of Johnson and Johnson, Merck and Bristol Myers Squibb answered questions as to why the price of their drugs are three times higher in the U.S. than in 33 other wealthy countries. Scott MacFarlane has more.
Why the Fed cut interest rates for the first time in 4 years
September 19, 2024
